BVHN Share Price | SKAN Group AG Stock Analysis & Recommendation

Results Declared: SKAN Group AG has declared results on 24 Mar 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare SKAN Group AG with Similar Stocks

Medacta Group SA Straumann Holding AG Alcon AG

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Negative results in Jun 25

With ROE of 17.36%, it has a Very Expensive valuation with a 6.70 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CHF 1,088 Million ()

P/E

39.00

Industry P/E

Dividend Yield

38.49%

Debt Equity

-1.53

Return on Equity

17.36%

Price to Book

6.14

Revenue and Profits:

Net Sales:

11 Million

(Quarterly Results - Dec 2020)

Net Profit:

11 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-42.35%

6 Months

-41.32%

1 Year

-48.3%

2 Years

-44.17%

3 Years

-19.17%

4 Years

0.0%

5 Years

0.0%

SKAN Group AG for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-5.33%

EBIT Growth (5y)

-5.68%

EBIT to Interest (avg)

13.54

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.33

Tax Ratio

Dividend Payout Ratio

23.18%

Pledged Shares

Institutional Holding

ROCE (avg)

20.32%

ROE (avg)

17.55%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.70

EV to EBIT

88.57

EV to EBITDA

88.57

EV to Capital Employed

9.13

EV to Sales

81.95

PEG Ratio

38.59

Dividend Yield

35.28%

ROCE (Latest)

10.31%

ROE (Latest)

17.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'20 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2020 is -27.74% vs 384.38% in Dec 2019",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2020 is -29.33% vs 400.00% in Dec 2019",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'20",
        "Dec'19",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.20",
          "val2": "15.50",
          "chgp": "-27.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.60",
          "val2": "15.00",
          "chgp": "-29.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.60",
          "val2": "15.00",
          "chgp": "-29.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.91% vs 15.52% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 46.24% vs 30.37% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "361.30",
          "val2": "320.00",
          "chgp": "12.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.00",
          "val2": "50.10",
          "chgp": "13.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.00",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.80",
          "val2": "27.90",
          "chgp": "46.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "123.10%",
          "val2": "118.00%",
          "chgp": "0.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'20 - YoY

Dec'20

Dec'19

Change(%)

Net Sales

11.20

15.50

-27.74%

Operating Profit (PBDIT) excl Other Income

10.60

15.00

-29.33%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

10.60

15.00

-29.33%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2020 is -27.74% vs 384.38% in Dec 2019

Standalone Net Profit

YoY Growth in quarter ended Dec 2020 is -29.33% vs 400.00% in Dec 2019

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

361.30

320.00

12.91%

Operating Profit (PBDIT) excl Other Income

57.00

50.10

13.77%

Interest

0.90

1.00

-10.00%

Exceptional Items

0.00

Consolidate Net Profit

40.80

27.90

46.24%

Operating Profit Margin (Excl OI)

123.10%

118.00%

0.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 12.91% vs 15.52% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 46.24% vs 30.37% in Dec 2023

All Annual Results

Company CV

About SKAN Group AG

SKAN Group AG

Pharmaceuticals & Biotechnology

BV Holding AG is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland and bordering countries. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

Company Coordinates

Company Details

Hofgut, Vordere Dorfgasse 12 , GUEMLIGEN None : 3073

Tel: 41 31 380185041 31 3801850

http://www.bvgroup.ch/

Registrar Details